CCL18 and breast carcinoma: CCL18 treatment for 6 or 8 hr enhanced the migration and invasion of breast cancer cells that were transfected with a negative control or mock-transfected by 4- and 3-fold, respectively (Figure 5C, 5D; Figure SF, SG).